Profile data is unavailable for this security.
About the company
TYK Medicines Inc is a China-based company mainly engaged in developing and commercializing pharmaceutical products. The Company is primarily focused on small molecule drug development, and its main products include TY-9591, TY-302 and TY-2136. TY-9591 is a third-generation EGFR-TKI with antitumor effects on EGFR mutations. TY-302 is a potent, selective oral CDK4/6 inhibitor developed for the treatment of advanced solid tumors, including breast cancer and prostate cancer. TY-2136b is an internally developed, oral ROS1/NTRK inhibitor for the treatment of solid tumors.
- Revenue in HKD (TTM)121.19k
- Net income in HKD-317.21m
- Incorporated2017
- Employees163.00
- LocationTYK Medicines Inc500 Yunjin Road, Greenland VilSHANGHAI 200030ChinaCHN
- Phone+86 2 161676766
- Fax+86 2 160107317
- Websitehttps://www.tykmedicines.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hanx Biopharmaceuticals (Wuhan) Co Ltd | -100.00bn | -100.00bn | 2.61bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -52.30 | -- | -- | -- |
| Clover Biopharmaceuticals Ltd | 58.64m | -1.03bn | 2.86bn | 243.00 | -- | -- | -- | 48.70 | -0.8203 | -0.8203 | 0.0466 | -1.49 | 0.0433 | 0.0547 | 47.89 | 195,458.50 | -76.07 | -75.37 | -- | -188.14 | 62.57 | -- | -1,756.85 | -13,419.00 | 0.2541 | -- | -- | -- | -2.13 | -- | -552.11 | -- | -24.90 | -- |
| Hua Medicine | 419.81m | 1.22bn | 3.21bn | 285.00 | 2.48 | 2.49 | 2.55 | 7.65 | 1.23 | 1.23 | 0.4253 | 1.22 | 0.2411 | 1.76 | 5.71 | 2,498,850.00 | 69.99 | -21.83 | 82.64 | -25.31 | 52.55 | -- | 290.30 | -395.24 | 7.00 | -- | 0.2038 | -- | 234.02 | -- | -18.42 | -- | -17.81 | -- |
| BioDlink International Co Ltd | 1.21bn | 8.22m | 3.25bn | 604.00 | 370.46 | 3.92 | 35.51 | 2.69 | 0.0113 | 0.0113 | 1.67 | 1.07 | 0.7275 | 2.35 | 5.49 | 1,977,613.00 | 0.495 | -11.37 | 0.6586 | -14.89 | 71.10 | 73.14 | 0.6805 | -24.91 | 1.68 | 1.83 | 0.3519 | -- | 40.70 | 89.20 | 192.05 | -- | 27.04 | -- |
| Medtide Inc | -100.00bn | -100.00bn | 3.73bn | 520.00 | -- | 2.24 | -- | -- | -- | -- | -- | 11.73 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 4.48 | -- | 0.0335 | -- | 31.31 | -- | 21.00 | -- | -- | -- |
| Visen Pharmaceuticals | -100.00bn | -100.00bn | 3.80bn | 54.00 | -- | 3.62 | -- | -- | -- | -- | -- | 9.23 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0014 | -- | -- | -- | 26.98 | -- | -- | -- |
| Qyuns Therapeutics Co Ltd | 362.84m | -217.22m | 4.64bn | 337.00 | -- | 17.88 | -- | 12.77 | -0.978 | -0.978 | 1.63 | 1.15 | 0.2903 | 4.05 | 9.14 | 1,070,314.00 | -17.90 | -- | -28.45 | -- | 72.44 | -- | -61.64 | -- | 1.43 | -23.19 | 0.7466 | -- | -- | -- | 33.91 | -- | -- | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 228.07m | -51.70m | 4.72bn | 211.00 | -- | 4.82 | -- | 20.70 | -0.0668 | -0.0668 | 0.2948 | 1.25 | 0.1547 | -- | 7.97 | 887,438.90 | -3.51 | -36.09 | -4.01 | -39.58 | 100.00 | 65.67 | -22.67 | -283.16 | -- | -- | 0.1415 | -- | 145.13 | -- | 56.64 | -- | 29.33 | -- |
| TYK Medicines Inc | 121.19k | -317.21m | 4.86bn | 163.00 | -- | 11.74 | -- | 40,143.25 | -0.8554 | -0.8554 | 0.0003 | 1.09 | 0.0002 | -- | -- | 792.07 | -42.68 | -- | -- | -- | 13.08 | -- | -263,981.30 | -- | -- | -- | 0.3215 | -- | -- | -- | -1.18 | -- | -- | -- |
| Laekna Inc | 0.00 | -272.08m | 5.56bn | 84.00 | -- | 6.29 | -- | -- | -0.7398 | -0.7398 | 0.00 | 1.98 | 0.00 | -- | -- | 0.00 | -27.79 | -- | -34.25 | -- | -- | -- | -- | -- | -- | -- | 0.1383 | -- | -- | -- | 31.05 | -- | -- | -- |
| Edding Genor Group Holdings Ltd | 253.70m | 22.82m | 6.09bn | 17.00 | 67.63 | 1.28 | 175.08 | 24.00 | 0.0450 | 0.0450 | 0.4885 | 2.37 | 0.1724 | -- | 5.21 | 10,571,020.00 | 1.46 | -48.63 | 1.72 | -55.19 | 99.56 | 97.88 | 8.45 | -2,303.07 | -- | -- | 0.0007 | -- | -- | 73.71 | 92.40 | -- | -43.79 | -- |
| MiRXES Holding Co Ltd | -100.00bn | -100.00bn | 6.59bn | 347.00 | -- | 7.40 | -- | -- | -- | -- | -- | 2.99 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.83 | -- | 0.1682 | -- | -16.14 | -- | -33.37 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to TYK Medicines Inc's reporting currency: Hong Kong Dollar HKD
1.86%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 2.33m | 0.62% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 1.40m | 0.37% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2025 | 820.00k | 0.22% |
| E Fund Asset Management Co. Ltd.as of 30 Jun 2025 | 631.00k | 0.17% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 501.00k | 0.13% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 425.50k | 0.11% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 274.00k | 0.07% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 254.00k | 0.07% |
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 215.50k | 0.06% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 143.00k | 0.04% |
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
